Lactate Metabolic Reprogramming Reverses CD8⁺ T Cell Exhaustion: A New Target for Cancer Immunotherapy
DOI:
https://doi.org/10.63808/ghc.v2i1.535Keywords:
Lactate metabolism, CD8⁺ T cell depletion, Tumor microenvironment, Immunotherapy, Metabolic reprogramming, MCT1/4, Histone lactation, Anti-PD-1Abstract
Lactate accumulation in the tumor microenvironment is an important factor inducing CD8⁺ T cell exhaustion and immunotherapy resistance, but whether reprogramming lactate metabolism can reverse CD8⁺ T cell exhaustion remains unclear. This study aims to explore the effects of targeted lactate metabolism on CD8⁺ T cell function and anti-tumor immunotherapy. Single-cell RNA sequencing, metabolomics, flow cytometry, and immunohistochemistry were used to analyze the lactate metabolism characteristics and exhaustion phenotypes of tumor-infiltrated CD8⁺ T cells; Genetics or pharmacological methods were used to regulate lactate dehydrogenase A (LDHA) and the lactate transporter MCT1/4, and to evaluate anti-tumor effects and synergistic effects with anti-PD-1 therapy in tumor-bearing mouse models of B16-OVA and MC38. Lactate uptake in tumor-infiltrating CD8⁺ T cells increases, with significant upregulation of MCT1/4 and LDHA, accompanied by decreased mitochondrial membrane potential, impaired oxidative phosphorylation, and increased expression of depletion markers such as PD-1, TIM-3, LAG-3, and TOX/NR4A. Inhibiting LDHA or blocking MCT1/4 lowers intracellular lactate levels, restores mitochondrial function and oxidative phosphorylation, enhances secretion of IFN-γ, TNF-α, and granzyme B, and downregulates depletion-related transcriptional programs. In tumor-bearing mice, reprogramming of lactate metabolism significantly inhibits tumor growth, increases the proportion of tumor-infiltrating CD8⁺ T cells and effector memory phenotypes, and produces synergistic effects with anti-PD-1 therapy. Mechanistically, lactate regulates the expression of exhaustion-related genes through histone lactation modification, while metabolic intervention can reverse this epigenetic program. Targeted lactate metabolism reprogramming can effectively reverse CD8⁺ T cell exhaustion, enhance the efficacy of tumor immunotherapy, and provide new potential targets for solid tumor immunotherapy.
References
[1] Bengsch, B., Johnson, A. L., Kurachi, M., Odorizzi, P. M., Pauken, K. E., Attanasio, J., et al. (2016). Bioenergetic insufficiencies due to metabolic alterations regulated by the inhibitory receptor PD-1 are an early driver of CD8+ T cell exhaustion. Immunity, 45(2), 358-373. https://doi.org/10.1016/j.immuni.2016.07.008
[2] Brand, A., Singer, K., Koehl, G. E., Kolitzus, M., Schoenhammer, G., Thiel, A., et al. (2016). LDHA-associated lactic acid production blunts tumor immunosurveillance by T and NK cells. Cell Metab, 24(5), 657-671. https://doi.org/10.1016/j.cmet.2016.08.011
[3] Buck, M. D., O’Sullivan, D., & Pearce, E. L. (2015). T cell metabolism drives immunity. J Exp Med, 212(9), 1345-1360. https://doi.org/10.1084/jem.20151159
[4] Chen, J., López-Moyado, I. F., Seo, H., Lio, C. J., Hempleman, L. J., Sekiya, T., et al. (2019). NR4A transcription factors limit CAR T cell function in solid tumours. Nature, 567(7749), 530-534. https://doi.org/10.1038/s41586-019-0985-x
[5] Colegio, O. R., Chu, N. Q., Szabo, A. L., Chu, T., Rhebergen, A. M., Jairam, V., et al. (2014). Functional polarization of tumour-associated macrophages by tumour-derived lactic acid. Nature, 513(7519), 559-563. https://doi.org/10.1038/nature13490
[6] Fischer, K., Hoffmann, P., Voelkl, S., Meidenbauer, N., Ammer, J., Edinger, M., et al. (2007). Inhibitory effect of tumor cell-derived lactic acid on human T cells. Blood, 109(9), 3812-3819. https://doi.org/10.1182/blood-2006-07-035972
[7] Halestrap, A. P. (2012). The monocarboxylate transporter family—structure and functional characterization. IUBMB Life, 64(1), 1-9. https://doi.org/10.1002/iub.573
[8] Hanahan, D., & Weinberg, R. A. (2011). Hallmarks of cancer: the next generation. Cell, 144(5), 646-674. https://doi.org/10.1016/j.cell.2011.02.013
[9] Khan, O., Giles, J. R., McDonald, S., Manne, S., Ngiow, S. F., Patel, K. P., et al. (2019). TOX transcriptionally and epigenetically programs CD8+ T cell exhaustion. Nature, 571(7764), 211-218. https://doi.org/10.1038/s41586-019-1325-x
[10] Liu G. (2026b). Tumor microenvironment: composition, dynamic evolution, and its significance in cancer treatment. Journal of Cancer Insights, 1(1), 6. https://doi.org/10.66128/jci202601.1
[11] Liu, G. (2026a). The application of artificial intelligence in tumor immunotherapy: integrating multi-omics data to achieve efficacy prediction and combination strategies. Applied Artificial Intelligence Research, 2(2). https://doi.org/10.65455/q72yq328
[12] Liu, G., Wang, J., & An, L. (2026a). CRISPR screen and single-cell multi-omics identify a novel immune checkpoint on tumor-infiltrating regulatory T cells. Injury and Rehabilitation Care, 2(1). https://doi.org/10.63808/irc.v2i1.525
[13] Liu, G., Wang, J., & An, L. (2026b). Gut microbiota-derived butyrate induces trained immunity in intestinal macrophages to potentiate antitumor immunity. Biology and Medical Engineering, 2(1). https://doi.org/10.63808/bm.v2i1.523
[14] Liu, G., Wang, J., & An, L. (2026c). Mitochondrial DNA sensing reshapes the tumor immune microenvironment via cooperative cGAS-STING activation and ferroptosis. Global Health Care, 2(1). https://doi.org/10.63808/ghc.v2i1.524
[15] Liu, G., Wang, J., & Zhu, J. (2026d). Explainable spatial AI analyzes tumor-immune interactions to predict immunotherapy outcomes and identify new targets. Intelligent & Human Futures, 2(3). https://doi.org/10.63808/ihf.v2i3.510
[16] Liu, G., Wang, J., & Zhu, J. (2026e). Using multimodal foundational models to predict neoantigen immunogenicity and vaccine effectiveness across different tumor types. Global Health Care, 2(3). https://doi.org/10.63808/ghc.v2i3.498
[17] Patsoukis, N., Bardhan, K., Chatterjee, P., Sari, D., Liu, B., Bell, L. N., et al. (2015). PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation. Nat Commun, 6, 6692. https://doi.org/10.1038/ncomms7692
[18] Vardhana, S. A., Hwee, M. A., Berisa, M., Wells, D. K., Yost, K. E., King, B., et al. (2020). Impaired mitochondrial oxidative phosphorylation limits the self-renewal of T cells exposed to persistent antigen. Nat Immunol, 21(9), 1022-1033. https://doi.org/10.1038/s41590-020-0725-2
[19] Warburg, O. (1956). On the origin of cancer cells. Science, 123(3191), 309-314. https://doi.org/10.1126/science.123.3191.309
[20] Wherry, E. J. (2011). T cell exhaustion. Nat Immunol, 12(6), 492-499. https://doi.org/10.1038/ni.2035
[21] Xiong, J., He, J., Zhu, J., Pan, J., Liao, W., Ye, H., et al. (2022). Lactylation-driven METTL3-mediated RNA m6A modification promotes immunosuppression of tumor-infiltrating myeloid cells. Mol Cell, 82(9), 1660-1677.e10. https://doi.org/10.1016/j.molcel.2022.02.033
[22] Zhang, D., Tang, Z., Huang, H., Zhou, G., Cui, C., Weng, Y., et al. (2019). Metabolic regulation of gene expression by histone lactylation. Nature, 574(7779), 575-580. https://doi.org/10.1038/s41586-019-1678-1
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Gang Liu, Jia Wang, Alena Mikalaeuna Vasiukevich, Biao Feng, Liqiang An
This work is licensed under a Creative Commons Attribution 4.0 International License.